Table 1.
Primay Results | Secondary Results |
---|---|
|
Is there an increased risk of death for patients with AP during the COVID-19 pandemic and, if so, can this be quantified? Did COVID-19 infection have an impact on the clinical outcomes and survival rate of patients with AP? Can COVID-19 infection exacerbate the risk of death in patients with AP and, if so, can this be numerically evaluated? |